7 documents found, page 1 of 1
Concepts for the Development of Person-Centered, Digitally Enabled, Artificial ...
Bousquet, Jean; Schünemann, Holger J.; Sousa-Pinto, Bernardo; Zuberbier, Torsten; Togias, Alkis; Samolinski, Boleslaw; Bedbrook, AnnaFunding Information: This work has received funding from ARIA (Allergic Rhinitis and its Impact of Asthma); CATALYSE (Climate Action To Advance HeaLthY Societies in Europe), the European Union\u2019s Horizon Europe research and innovation program under grant agreement no. 101057131; FRAUNHOFER Institute for Translational Medicine and Pharmacology (ITMP), Immunology and Allergology, Berlin, Germany; University o...
Rhinitis associated with asthma is distinct from rhinitis alone
Bousquet, J; Melén, E; Haahtela, T; Koppelman, G H; Togias, A; Valenta, R; Akdis, C A; Czarlewski, W; Rothenberg, M; Valiulis, A; Wickmann, M; Bonini, MAsthma, rhinitis and atopic dermatitis (AD) are interrelated clinical phenotypes that partly overlap in the human interactome. The concept of "one-airway-one-disease", coined over 20 years ago, is a simplistic approach of the links between upper- and lower-airway allergic diseases. With new data, it is time to reassess the concept. This article reviews (i) the clinical observations that led to Allergic Rhinitis...
Consistent trajectories of rhinitis control and treatment in 16,177 weeks
Sousa-Pinto, Bernardo; Schünemann, Holger J.; Sá-Sousa, Ana; Vieira, Rafael José; Amaral, Rita; Anto, Josep M.; Klimek, Ludger; Czarlewski, WienczyslawaFunding Information: MASK‐air® has been supported by EU grants (POLLAR, EIT Health; Structural and Development Funds, Twinning, EIP on AHA and H2020) and educational grants from Mylan‐Viatris, ALK, GSK, Novartis and Uriach. Publisher Copyright: © 2022 The Authors. Allergy published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.; Introduction: Data from mHealth apps can provide...
Behavioural patterns in allergic rhinitis medication in Europe
Sousa-Pinto, Bernardo; Sá-Sousa, Ana; Vieira, Rafael José; Amaral, Rita; Klimek, Ludger; Czarlewski, Wienczyslawa; Antó, Josep M; Pfaar, OliverFunding: This study was funded by ARIA. MASK-air® has been supported by EU grants (EU Structural and Development grant, POLLAR: EIT Health and Structural and Development Funds) and educational grants from Mylan-Viatris, ALK, GSK, Novartis and Uriach. Open Access funding enabled and organized by Projekt DEAL.; BACKGROUND: Co-medication is common among patients with allergic rhinitis (AR), but its dimension and p...
Allergen immunotherapy in MASK-air users in real-life
Sousa-Pinto, Bernardo; Azevedo, Luís Filipe; Sá-Sousa, Ana; Vieira, Rafael José; Amaral, Rita; Klimek, Ludger; Czarlewski, Wienczyslawa; Anto, Josep M.Funding Information: MASK-air has been supported by Charit? Universit?tsmedizin Berlin, EU Grants (EU Structural and Development Funds, POLLAR: EIT Health POLLAR, EIT Health Twinning) and educational grants from Mylan-Viatris, ALK, GSK, Novartis and Uriach. Open access funding enabled and organized by Projekt DEAL. Publisher Copyright: © 2022 The Authors. Clinical and Translational Allergy published by John Wil...
Comparison of rhinitis treatments using MASK-air® data and considering the mini...
Sousa-Pinto, Bernardo; Schünemann, Holger J.; Sá-Sousa, Ana; Vieira, Rafael José; Amaral, Rita; Anto, Josep M.; Klimek, Ludger; Czarlewski, WienczyslawaFunding Information: IA reports personal fees from Roxall, Menarini, UCB, Faes Farma, Sanofi, Bial, Amgen, Abbott, Bayer, Organon. SBA reports grants from TEVA, personal fees from TEVA, AstraZeneca, Boehringer Ingelheim, GSK, Sanofi, Mylan. JB reports personal fees from Chiesi, Cipla, Hikma, Menarini, Mundipharma, Mylan, Novartis, Sanofi‐Aventis, Takeda, Teva, Uriach, other from KYomed‐Innov, personal fees from...
ARIA-EAACI care pathways for allergen immunotherapy in respiratory allergy
Bousquet, Jean; Pfaar, Oliver; Agache, Ioana; Bedbrook, Anna; Akdis, Cezmi A.; CANONICA, GIORGIO WALTER; Chivato, Tomas; Al-Ahmad, MonaFunding Information: BSreports personal fees from Allergopharma, during the conduct of the study; grants from National Health Programm, grant, personal fees from Polpharma, ASTRA, personal fees from Mylan, Adamed, patient ombudsman, national Centre for Research and Development, Polish Allergology Society. Funding Information: NGP reports personal fees from Novartis, Nutricia, HAL, MENARINI/FAES FARMA, SANOFI, M...